Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy

Diabetes Care. 1999 Jun;22(6):1006-8. doi: 10.2337/diacare.22.6.1006.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Albuminuria
  • Diabetic Nephropathies / blood
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / urine
  • Humans
  • Pentoxifylline / therapeutic use*
  • Proteinuria*
  • Tumor Necrosis Factor-alpha / metabolism
  • Tumor Necrosis Factor-alpha / urine
  • Vasodilator Agents / therapeutic use

Substances

  • Tumor Necrosis Factor-alpha
  • Vasodilator Agents
  • Pentoxifylline